Human Genome Sciences, Inc. · Rockville, MD United States ·(NASDAQ (GM): HGSI)
Company Description
View Human Genome Sciences, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Human Genome Sciences (HGS) knows that the path to good health starts at the molecular level. Using its expertise in human genetics, the firm is working on therapies for infectious and autoimmune diseases and cancer. One of its lead candidates is Albuferon, a long-acting version of protein therapy interferon alpha, that it is developing with Novartis to treat hepatitis C. Monoclonal antibody LymphoStat-B is also in later stages of clinical testing; GlaxoSmithKline is HGS' partner on the drug. With funding from the US government, HGS is developing an antibody that fights anthrax infection, and it has several anticancer antibodies at earlier stages of development. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Human Genome Sciences, Inc. Financials
| Company Type | Public - NASDAQ (GM): HGSI Headquarters |
| Fiscal Year-End | December |
| 2008 Sales (mil.) | $48.4 |
| 2008 Employees | 880 |
Human Genome Sciences, Inc. Executives
29 executives listed for Human Genome Sciences, Inc.'s Rockville, MD location.
| Title | Name & Bio | Contact |
| Chairman | Argeris Karabelas | Network |
| President, CEO, and Director | H. Thomas Watkins | Network |
| SVP Operations | Curran Simpson | Network |
Competition
Competitive Landscape for Human Genome Sciences, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Human Genome Sciences, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!